CHINATRIALS 17: Global R&D Leaders' Summit

November 12-14, 2025 - Shanghai

CHINATRIALS 17: Global R&D Leaders' Summit returns to Shanghai on November 12-14, 2025 and will again provide the year's best opportunity to share China clinical development strategies.

Since its inception in 2008, the ChinaTrials Summit has been a cornerstone for the global clinical development industry. Now, in 2025, with Chinese biotechs expanding their presence on the global stage and multinational pharmaceutical and biotech companies seeking innovative licensing opportunities, the Summit is returning to its global roots with a bold, refreshed vision.

The biopharma industry is entering a new era of global innovation, and China is at the forefront of this transformation. With its rapid advancements in cutting-edge therapies, growing influence in international markets, and increased appetite for global partnerships, the time is right for ChinaTrials to reconnect the global community and provide a space where East meets West in the pursuit of innovation-driven collaboration.

Join us for this exciting new chapter of the ChinaTrials Summit as we re-establish our commitment to global collaboration, visionary leadership, and the future of life sciences innovation. Together, we will shape the next frontier of global biopharma R&D- anchored by the clinical development expertise that has defined ChinaTrials from the very beginning.

For more information, contact Lychee.

REGISTRATION DETAILS

R&D Company Rate
$995 USD / 7,600 RMB (Early Bird R&D Rate before August 30, 2024)
$1,295 USD / 9,900 RMB (R&D Rate after August 30, 2024)
If your company has a drug or device in preclinical/clinical development, or a product already on the market, you are eligible for the R&D rate.

R&D Company Group Rates*
*If you are an R&D Company and your team is interested in sending multiple attendees, please email us at [email protected] to register as a group. The group discounts are listed below.

Group Rate A (2 to 4 Attendees) $750 USD / 5,700 RMB per attendee
Group Rate B (5+ Attendees) $585 USD / 4,500 RMB per attendee

China Emerging Company Rate
$500 USD / 3,800 RMB

If your company is a new/small/developing domestic Chinese company, you may be eligible for a special discounted rate. Those eligible for this special rate include Founders, CEOs, CFOs, and other senior management of China-based healthcare operating companies in the products/services areas in the "new," "young" or "start-up" phase. This rate excludes consultants, advisers, established companies, etc. China Emerging Rate is subject to approval by Lychee Group. Please email Eric Lu at [email protected] to confirm your eligibility. If approved, you will then be sent the required code to enter that will enable you to register at this special rate.

Government employees and those working at academic institutions are also eligible for this rate. Workshops are included with this rate.

Standard Rate
$1,395 USD / 10,650 RMB (Early Bird Standard Rate before August 30, 2024)
$1,695 USD / 12,990 RMB (Standard Rate after August 30, 2024)

If you are not eligible for the R&D Rate or the China Emerging Company Rate option listed below, you must select Standard Attendee when registering.

Registration Options

BioPharma R&D Company Rate ($995.00)
*For the China Emerging Company Rate, please choose this option and enter your code.
Standard Rate ($1,395.00)

Name

Title

Company

Address

Phone Number

Yes, it's okay to send me text messages including confirmations, changes, updates, and/or promotions. Message frequency varies. Message and data rates may apply. View our terms of service & privacy policy.

Subtotal

$0.00

Promo Code

Total

$0.00

Billing Information

Name

I am representing an organization

Credit Card

Visa
Mastercard
American Express
Discover

Address

This page is secured with 256 bit encryption

Event Registration Software by RegFox